BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,485,393 | -2.8% | 607,037 | +22.4% | 1.48% | +7.7% |
| Q2 2023 | $31,350,550 | +59.0% | 496,053 | +13.2% | 1.37% | +45.0% |
| Q1 2023 | $19,716,823 | +15.1% | 438,249 | +12.0% | 0.95% | +14.3% |
| Q4 2022 | $17,136,544 | -18.4% | 391,156 | +22.8% | 0.83% | -23.5% |
| Q3 2022 | $20,991,000 | +15.5% | 318,574 | +87.8% | 1.08% | +61.4% |
| Q4 2021 | $18,172,000 | -24.3% | 169,659 | -27.3% | 0.67% | -23.1% |
| Q3 2021 | $24,007,000 | +20.6% | 233,508 | +3.2% | 0.87% | +20.3% |
| Q2 2021 | $19,908,000 | -21.3% | 226,335 | -13.0% | 0.72% | -20.6% |
| Q1 2021 | $25,293,000 | -24.3% | 260,134 | -12.7% | 0.91% | -17.7% |
| Q4 2020 | $33,410,000 | -5.3% | 297,905 | -21.7% | 1.11% | -23.6% |
| Q3 2020 | $35,281,000 | +14.4% | 380,589 | -3.8% | 1.45% | +8.0% |
| Q2 2020 | $30,848,000 | +26.8% | 395,485 | -5.0% | 1.34% | -4.5% |
| Q1 2020 | $24,337,000 | – | 416,166 | – | 1.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 379,090 | $19,037,900 | 17.25% |
| DAFNA Capital Management LLC | 249,521 | $12,530,945 | 3.90% |
| Rock Springs Capital Management LP | 2,685,294 | $134,855,465 | 3.61% |
| Casdin Capital, LLC | 371,378 | $18,650,603 | 2.06% |
| Novo Holdings A/S | 525,000 | $26,365,500 | 1.95% |
| CHI Advisors LLC | 92,888 | $4,664,835 | 1.85% |
| SECTORAL ASSET MANAGEMENT INC | 165,890 | $8,330,996 | 1.62% |
| Avidity Partners Management LP | 751,600 | $37,745,352 | 1.52% |
| EMERALD ADVISERS, LLC | 607,037 | $30,485,393 | 1.48% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 464,321 | $23,318,201 | 1.41% |